Literature DB >> 17076597

Delivery systems and adjuvants for oral vaccines.

Ed C Lavelle1, D T O'Hagan.   

Abstract

The oral route is the ideal means of delivering prophylactic and therapeutic vaccines, offering significant advantages over systemic delivery. Most notably, oral delivery is associated with simple administration and improved safety. In addition, unlike systemic immunisation, oral delivery can induce mucosal immune responses. However, the oral route of vaccine delivery is the most difficult because of the numerous barriers posed by the gastrointestinal tract. To facilitate effective immunisation with peptide and protein vaccines, antigens must be protected, uptake enhanced and the innate immune response activated. Numerous delivery systems and adjuvants have been evaluated for oral vaccine delivery, including live vectors, inert particles and bacterial toxins. Although developments in oral vaccines have been disappointing so far, in terms of the generation of products, the availability of a range of novel delivery systems offers much greater hope for the future development of improved oral vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076597     DOI: 10.1517/17425247.3.6.747

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  26 in total

Review 1.  Feasibility of Pisum sativum as an expression system for pharmaceuticals.

Authors:  Heike Mikschofsky; Inge Broer
Journal:  Transgenic Res       Date:  2011-11-06       Impact factor: 2.788

Review 2.  Vaccines are for dinner.

Authors:  David W Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

Review 3.  Controlled delivery systems: from pharmaceuticals to cells and genes.

Authors:  Elizabeth Rosado Balmayor; Helena Sepulveda Azevedo; Rui L Reis
Journal:  Pharm Res       Date:  2011-03-19       Impact factor: 4.200

Review 4.  Identifying human and murine M cells in vitro.

Authors:  Ana Klisuric; Benjamin Thierry; Ludivine Delon; Clive A Prestidge; Rachel J Gibson
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-24

5.  Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.

Authors:  Jacob C McCright; Katharina Maisel
Journal:  Tissue Barriers       Date:  2019-11-28

6.  Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes.

Authors:  Lasse Fredriksen; Charlotte R Kleiveland; Lene T Olsen Hult; Tor Lea; Cathrine S Nygaard; Vincent G H Eijsink; Geir Mathiesen
Journal:  Appl Environ Microbiol       Date:  2012-06-15       Impact factor: 4.792

Review 7.  Nanoparticle-based approaches to target the lymphatic system for antitumor treatment.

Authors:  Xingzhou Peng; Junjie Wang; Feifan Zhou; Qian Liu; Zhihong Zhang
Journal:  Cell Mol Life Sci       Date:  2021-05-08       Impact factor: 9.261

Review 8.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

9.  Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.

Authors:  Aurelie Kern; Chensheng W Zhou; Feng Jia; Qiaobing Xu; Linden T Hu
Journal:  Vaccine       Date:  2016-08-05       Impact factor: 3.641

10.  Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Authors:  Philip A Arlen; Michael Singleton; Jeffrey J Adamovicz; Yi Ding; Abdolreza Davoodi-Semiromi; Henry Daniell
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.